• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2019-2021 年,卡拉布里亚地区儿科人群 1 型糖尿病发病率呈上升趋势。

Increasing trend of type 1 diabetes incidence in the pediatric population of the Calabria region in 2019-2021.

机构信息

Department of Human Pathology in Adult and Developmental Age "Gaetano Barresi", University of Messina, Via Consolare Valeria 1, 98124, Messina, ME, Italy.

S.O.C Pediatria, Ospedale Civile "Giovanni Paolo II", Lamezia Terme, Italy.

出版信息

Ital J Pediatr. 2022 May 4;48(1):66. doi: 10.1186/s13052-022-01264-z.

DOI:10.1186/s13052-022-01264-z
PMID:35509062
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9066995/
Abstract

BACKGROUND

Although type 1 diabetes (T1D) represents one of the most common chronic diseases in pediatric age, few studies on the epidemiology of T1D exist globally and the exact prevalence and incidence rates of the disease are unknown. In many countries, including Italy, national registries are missing.

METHODS

This study aims to assess T1D incidence in the pediatric population of the Calabria region (southern Italy) in the period 2019-2021. The secondary objective was to describe the main demographical, clinical and immunological features of incident cases. Case ascertainment and all clinical data were assessed by retrospectively reviewing the electronic medical records of children and adolescents diagnosed with diabetes at any Pediatric Diabetes Center belonging to the Rete Diabetologica Calabrese (Calabria Region Diabetes Network), from January 2019 to December 2021. The incidence of T1D was estimated for the entire region and was stratified according to age group (0-4 years, 5-9 years, and 10-14 years) and gender. Standardized incidence ratios for each province in the region were also calculated.

RESULTS

The crude incidence of T1D was 20.6/100,000 person/years. Incidence rates were higher among females and children aged 5-9 years. The crude incidence of T1D was higher in the province of Reggio Calabria (26.5/100,000 person-years). The provinces of Crotone, Catanzaro, and Vibo Valentia showed significantly lower standardized incidence ratios. The annual incidence in the region progressively increased by 43% during the study period.

CONCLUSIONS

Our study revealed a relatively high incidence in the Calabria region. The marked increasing incidence trend over the past two years could be related to the global impact of the COVID-19 pandemic, but further long-scale population-based studies are needed to confirm these findings.

摘要

背景

尽管 1 型糖尿病(T1D)是儿科最常见的慢性疾病之一,但全球关于 T1D 流行病学的研究很少,该病的确切患病率和发病率尚不清楚。在包括意大利在内的许多国家,都缺乏国家登记。

方法

本研究旨在评估 2019-2021 年期间卡拉布里亚地区(意大利南部)儿科人群 T1D 的发病率。次要目标是描述新发病例的主要人口统计学、临床和免疫学特征。通过回顾性审查属于 Rete Diabetologica Calabrese(卡拉布里亚地区糖尿病网络)的任何儿科糖尿病中心在 2019 年 1 月至 2021 年 12 月期间诊断为糖尿病的儿童和青少年的电子病历,评估了 T1D 的病例发现和所有临床数据。T1D 的发病率在整个地区进行了估计,并按年龄组(0-4 岁、5-9 岁和 10-14 岁)和性别进行了分层。还计算了该地区每个省的标准化发病率比。

结果

T1D 的粗发病率为 20.6/100,000 人/年。女性和 5-9 岁儿童的发病率较高。雷焦卡拉布里亚省的 T1D 粗发病率较高(26.5/100,000 人年)。克罗斯托尼、卡坦扎罗和维博瓦伦蒂亚省的标准化发病率比明显较低。在研究期间,该地区的年发病率增加了 43%。

结论

我们的研究显示卡拉布里亚地区的发病率相对较高。过去两年发病率呈明显上升趋势,可能与 COVID-19 大流行的全球影响有关,但需要进一步进行大规模的基于人群的研究来证实这些发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38ab/9069790/c771fb7be23f/13052_2022_1264_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38ab/9069790/c771fb7be23f/13052_2022_1264_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38ab/9069790/c771fb7be23f/13052_2022_1264_Fig1_HTML.jpg

相似文献

1
Increasing trend of type 1 diabetes incidence in the pediatric population of the Calabria region in 2019-2021.2019-2021 年,卡拉布里亚地区儿科人群 1 型糖尿病发病率呈上升趋势。
Ital J Pediatr. 2022 May 4;48(1):66. doi: 10.1186/s13052-022-01264-z.
2
Incidences of newly diagnosed childhood diabetes and onset severity: a multicenter regional study in Thailand over two decades and during the COVID-19 pandemic.新诊断儿童糖尿病的发病率和发病严重程度:泰国 20 多年来和 COVID-19 大流行期间的多中心区域性研究。
J Pediatr Endocrinol Metab. 2024 Apr 16;37(6):487-496. doi: 10.1515/jpem-2024-0042. Print 2024 Jun 25.
3
Increase in the Diagnosis and Severity of Presentation of Pediatric Type 1 and Type 2 Diabetes during the COVID-19 Pandemic.在 COVID-19 大流行期间,儿科 1 型和 2 型糖尿病的诊断和发病严重程度增加。
Horm Res Paediatr. 2021;94(7-8):275-284. doi: 10.1159/000519797. Epub 2021 Sep 24.
4
Revisiting the Annual Incidence of Type 1 Diabetes Mellitus in Children from the Southeastern Anatolian Region of Turkey: A Regional Report.重新审视土耳其安纳托利亚东南部地区儿童1型糖尿病的年发病率:一份地区报告。
J Clin Res Pediatr Endocrinol. 2022 Jun 7;14(2):172-178. doi: 10.4274/jcrpe.galenos.2021.2021-10-7. Epub 2022 Jan 11.
5
Incidence of type 1 diabetes mellitus during 26 years of observation and prevalence of diabetic ketoacidosis in the later years.26年观察期内1型糖尿病的发病率及后期糖尿病酮症酸中毒的患病率。
Eur J Pediatr. 2015 Oct;174(10):1319-24. doi: 10.1007/s00431-015-2537-1. Epub 2015 Apr 17.
6
Increasing Co-occurrence of Additional Autoimmune Disorders at Diabetes Type 1 Onset Among Children and Adolescents Diagnosed in Years 2010-2018-Single-Center Study.2010-2018 年诊断的儿童和青少年 1 型糖尿病发病时合并其他自身免疫性疾病的发生率增加——单中心研究。
Front Endocrinol (Lausanne). 2020 Aug 6;11:476. doi: 10.3389/fendo.2020.00476. eCollection 2020.
7
Increased frequency of severe diabetic ketoacidosis at type 1 diabetes onset among children during COVID-19 pandemic lockdown: an observational cohort study.在 COVID-19 大流行封锁期间,1 型糖尿病发病时严重糖尿病酮症酸中毒的频率增加:一项观察性队列研究。
Pediatr Endocrinol Diabetes Metab. 2020;26(4):167-175. doi: 10.5114/pedm.2020.101003.
8
Evidence of increasing incidence of type 1 diabetes and ketoacidosis among children in the Republic of Srpska in period 2017-2022 with special focus on COVID-19 global pandemic years.在 2017-2022 年期间,斯普斯卡共和国儿童 1 型糖尿病和酮症酸中毒发病率不断上升的证据,特别关注 COVID-19 全球大流行期间。
Front Public Health. 2023 Sep 6;11:1264099. doi: 10.3389/fpubh.2023.1264099. eCollection 2023.
9
10-Year Incidence of Diabetic Ketoacidosis at Type 1 Diabetes Diagnosis in Children Aged Less Than 16 Years From a Large Regional Center (Hangzhou, China).中国杭州大型区域中心 16 岁以下儿童 1 型糖尿病诊断时糖尿病酮症酸中毒的 10 年发生率。
Front Endocrinol (Lausanne). 2021 Apr 27;12:653519. doi: 10.3389/fendo.2021.653519. eCollection 2021.
10
Diagnosis of type 1 diabetes during the SARS-CoV-2 pandemic: Does lockdown affect the incidence and clinical status of patients?SARS-CoV-2 大流行期间 1 型糖尿病的诊断:封锁是否会影响患者的发病率和临床状况?
Adv Clin Exp Med. 2021 Feb;30(2):127-134. doi: 10.17219/acem/130359.

引用本文的文献

1
Type 1 diabetes incidence during COVID-19 pandemic has not been influenced by COVID-19 vaccination in northern Italy region, Lombardy.在意大利北部的伦巴第地区,2型糖尿病的发病率在新冠疫情期间并未受到新冠疫苗接种的影响。 (原文中的“Type 1 diabetes”表述有误,结合语境这里应该是“Type 2 diabetes”,所以按照正确内容翻译)
PLoS One. 2025 Feb 10;20(2):e0316340. doi: 10.1371/journal.pone.0316340. eCollection 2025.
2
Incidence of Type 1 Diabetes in Children Aged 0-14 Years in Trentino-Alto Adige Region and Determinants of Onset with Ketoacidosis.特伦蒂诺-上阿迪杰地区0至14岁儿童1型糖尿病的发病率及酮症酸中毒发病的决定因素。
J Pers Med. 2024 Oct 11;14(10):1055. doi: 10.3390/jpm14101055.
3

本文引用的文献

1
Risk for Newly Diagnosed Diabetes >30 Days After SARS-CoV-2 Infection Among Persons Aged <18 Years - United States, March 1, 2020-June 28, 2021.2020 年 3 月 1 日至 2021 年 6 月 28 日期间,年龄<18 岁的 SARS-CoV-2 感染者在新冠病毒感染后 30 天以上新发糖尿病的风险。
MMWR Morb Mortal Wkly Rep. 2022 Jan 14;71(2):59-65. doi: 10.15585/mmwr.mm7102e2.
2
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2022.2. 糖尿病的分类和诊断:2022 年糖尿病医疗护理标准。
Diabetes Care. 2022 Jan 1;45(Suppl 1):S17-S38. doi: 10.2337/dc22-S002.
3
Increased Incidence of Type 1 Diabetes during the COVID-19 Pandemic in Romanian Children.
Impact of the COVID-19 pandemic on the incidence and clinical outcomes of diabetic ketoacidosis among male and female children with type 1 diabetes: systematic review and meta-analysis.
COVID-19 大流行对男性和女性 1 型糖尿病儿童中糖尿病酮症酸中毒发病率和临床结局的影响:系统评价和荟萃分析。
F1000Res. 2023 Aug 10;12:72. doi: 10.12688/f1000research.128687.2. eCollection 2023.
4
Progranulin and Vaspin as Potential Novel Markers in the Etiology of Type 1 Diabetes in Children.颗粒蛋白前体和内脂素作为儿童 1 型糖尿病发病机制中潜在的新型标志物。
Medicina (Kaunas). 2024 Jul 19;60(7):1165. doi: 10.3390/medicina60071165.
5
Use of teplizumab in children and adolescents at risk of type 1 diabetes: perspectives of parents and caregivers from an Italian Pediatric Diabetes Center.在意大利儿科糖尿病中心,使用 teplizumab 治疗处于 1 型糖尿病风险中的儿童和青少年:来自父母和照护者的观点。
Acta Diabetol. 2024 May;61(5):635-642. doi: 10.1007/s00592-024-02245-w. Epub 2024 Feb 21.
6
Differential evolution of diabetic ketoacidosis in adults with pre-existent versus newly diagnosed type 1 and type 2 diabetes mellitus.成人糖尿病酮症酸中毒在有预先存在的 1 型和 2 型糖尿病与新诊断的 1 型和 2 型糖尿病中的差异演变。
BMC Endocr Disord. 2023 Sep 12;23(1):193. doi: 10.1186/s12902-023-01446-8.
7
Advances for pediatricians in 2022: allergy, anesthesiology, cardiology, dermatology, endocrinology, gastroenterology, genetics, global health, infectious diseases, metabolism, neonatology, neurology, oncology, pulmonology.2022 年儿科医生的进展:过敏、麻醉学、心脏病学、皮肤病学、内分泌学、胃肠病学、遗传学、全球健康、传染病、代谢、新生儿学、神经病学、肿瘤学、肺病学。
Ital J Pediatr. 2023 Sep 8;49(1):115. doi: 10.1186/s13052-023-01522-8.
8
Endocrinological Involvement in Children and Adolescents Affected by COVID-19: A Narrative Review.新型冠状病毒肺炎(COVID-19)对儿童和青少年内分泌系统的影响:一篇叙述性综述
J Clin Med. 2023 Aug 11;12(16):5248. doi: 10.3390/jcm12165248.
9
Severe multiple organ failure as a consequence of diabetic ketoacidosis in an adolescent with new-onset type 1 diabetes: A case report.一名新发1型糖尿病青少年因糖尿病酮症酸中毒导致严重多器官功能衰竭:病例报告
SAGE Open Med Case Rep. 2023 Jul 31;11:2050313X231190004. doi: 10.1177/2050313X231190004. eCollection 2023.
10
Incidence of Diabetes in Children and Adolescents During the COVID-19 Pandemic: A Systematic Review and Meta-Analysis.儿童和青少年在 COVID-19 大流行期间的糖尿病发病率:系统评价和荟萃分析。
JAMA Netw Open. 2023 Jun 1;6(6):e2321281. doi: 10.1001/jamanetworkopen.2023.21281.
罗马尼亚儿童在 COVID-19 大流行期间 1 型糖尿病发病率上升。
Medicina (Kaunas). 2021 Sep 16;57(9):973. doi: 10.3390/medicina57090973.
4
Replacing insulin with immunotherapy: Time for a paradigm change in Type 1 diabetes.用免疫疗法替代胰岛素:1 型糖尿病治疗范式的变革时机已到。
Diabet Med. 2021 Dec;38(12):e14696. doi: 10.1111/dme.14696. Epub 2021 Sep 29.
5
Long-term complications of type 1 diabetes: what do we know and what do we need to understand?1 型糖尿病的长期并发症:我们了解什么,我们需要理解什么?
Minerva Pediatr (Torino). 2021 Dec;73(6):504-522. doi: 10.23736/S2724-5276.21.06545-9. Epub 2021 Sep 16.
6
Type 1 diabetes prevalence and incidence rates in the pediatric population of Veneto Region (Italy) in 2015-2020.2015-2020 年意大利威尼托地区儿科人群 1 型糖尿病的患病率和发病率。
Diabetes Res Clin Pract. 2021 Sep;179:109020. doi: 10.1016/j.diabres.2021.109020. Epub 2021 Aug 23.
7
Preventing type 1 diabetes in childhood.预防儿童 1 型糖尿病。
Science. 2021 Jul 30;373(6554):506-510. doi: 10.1126/science.abi4742.
8
Efficacy of advanced hybrid closed loop systems for the management of type 1 diabetes in children.先进的混合闭环系统在儿童 1 型糖尿病管理中的疗效。
Minerva Pediatr (Torino). 2021 Dec;73(6):474-485. doi: 10.23736/S2724-5276.21.06531-9. Epub 2021 Jul 26.
9
SARS-CoV-2 infects human pancreatic β cells and elicits β cell impairment.SARS-CoV-2 感染人类胰腺 β 细胞并引起 β 细胞损伤。
Cell Metab. 2021 Aug 3;33(8):1565-1576.e5. doi: 10.1016/j.cmet.2021.05.013. Epub 2021 May 18.
10
New-onset type 1 diabetes in Finnish children during the COVID-19 pandemic.新冠疫情期间芬兰儿童新发1型糖尿病情况
Arch Dis Child. 2022 Feb;107(2):180-185. doi: 10.1136/archdischild-2020-321220. Epub 2021 May 27.